Reviews in
Neuro-Oncology


Volume 21 Number 4
April 2019


Home > Disciplines > Publications > Reviews on Neuro-Oncology > Volume 21, Year 2019 > Number 4, April


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE MIDLINE GLIOMAS
HIGH-GRADE GLIOMAS
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

EPENDYMAL TUMORS
EPENDYMOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA
ATYPICAL THERATOID/RHABDOID TUMOR

LYMPHOMAS





CENTRAL NERVOUS SYSTEM TUMORS

.

Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, Gilbertson RJ.
Challenges to curing primary brain tumours.
Nat Rev Clin Oncol. 2019 Feb 7. doi: 10.1038/s41571-019-0177-5. [Epub ahead of print]
Source | Full text | Similar articles



.

Chi AS et al, PDQ Adult Treatment Editorial Board.
Adult Central Nervous System Tumors Treatment (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Feb 6.
Source | Book | Similar articles



.

Chukwueke UN, Wen PY.
Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice.
CNS Oncol. 2019 Mar 1;8(1):CNS28. doi: 10.2217/cns-2018-0007. Epub 2019 Feb 26.
Source | Full text | Similar articles



.

Janss AJ, Mazewski C, Patterson B.
Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors.
Curr Treat Options Oncol. 2019 Feb 9;20(1):10. doi: 10.1007/s11864-019-0602-0.
Source | Full text | Similar articles



.

Ruff MW, Uhm JH, Benarroch EE.
Neuro-oncology: Implications of the molecular era.
Neurology. 2019 Mar 19;92(12):568-574. doi: 10.1212/WNL.0000000000007126. Epub 2019 Feb 13.
Source | Full text | Similar articles



GLIOMAS

.

Daniel P, Sabri S, Chaddad A, Meehan B, Jean-Claude B, Rak J, Abdulkarim BS.
Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities.
Front Oncol. 2019 Feb 4;9:41. doi: 10.3389/fonc.2019.00041. eCollection 2019.
Source | Full text | Similar articles



.

Miklja Z, Pasternak A, Stallard S, Nicolaides T, Kline-Nunnally C, Cole B, Beroukhim R, Bandopadhayay P, Chi S, Ramkissoon SH, Mullan B, Bruzek AK, Gauthier A, Garcia T, Atchison C, Marini B, Fouladi M, Parsons DW, Leary S, Mueller S, Ligon KL, Koschmann C.
Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.
Neuro Oncol. 2019 Feb 26. pii: noz022. doi: 10.1093/neuonc/noz022. [Epub ahead of print]
Source | Full text | Similar articles



BRAIN STEM GLIOMAS




DIFFUSE MIDLINE GLIOMAS


.

Buus-Gehrig C, Lehrnbecher T, Porto L, Becker M, Freiman T, Mittelbronn M, Bochennek K.
Pontine tumor in a neonate: case report and analysis of the current literature.
J Neurosurg Pediatr. 2019 Feb 15:1-7. doi: 10.3171/2018.10.PEDS18215. [Epub ahead of print]
Source | Abstract | Similar articles



.

Himes BT, Zhang L, Daniels DJ.
Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges.
Front Oncol. 2019 Feb 8;9:31. doi: 10.3389/fonc.2019.00031. eCollection 2019.
Source | Full text | Similar articles



.

Mora J.
Editorial: Proceedings From the 4th Memorial Alicia Pueyo Workshop: "Moving Towards a Cure for Diffuse Intrinsic Pontine Glioma".
Front Oncol. 2019 Jan 31;9:42. doi: 10.3389/fonc.2019.00042. eCollection 2019.
Source | Full text | Similar articles



.

Traylor JI, Kuo JS.
"Liquid Biopsy" of Circulating Tumor DNA Characterizes Treatment Response in Pediatric Patients Diffuse Midline Glioma.
Neurosurgery. 2019 Feb 22. pii: nyz029. doi: 10.1093/neuros/nyz029. [Epub ahead of print]
Source | Full text | Similar articles
Article review referring to:
Panditharatna E, et al., Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
Clin Cancer Res. 2018 Dec 1;24(23):5850-5859. doi: 10.1158/1078-0432.CCR-18-1345. Epub 2018 Oct 15.
Source | Full text



HIGH-GRADE GLIOMAS


.

Pierscianek D, Ahmadipour Y, Oppong MD, Rauschenbach L, Kebir S, Glas M, Sure U, Jabbarli R.
Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review.
Mol Neurobiol. 2019 Feb 4. doi: 10.1007/s12035-019-1509-2. [Epub ahead of print]
Source | Full text | Similar articles



LOW-GRADE GLIOMAS


.

Schiff D, van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY.
Recent Developments and Future Directions in Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Consensus.
Neuro Oncol. 2019 Feb 8. doi: 10.1093/neuonc/noz033. [Epub ahead of print]
Source | Abstract | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA


.

Baratta MG.
Glioblastoma is 'hot' for personalized vaccines.
Nat Rev Cancer. 2019 Mar;19(3):129. doi: 10.1038/s41568-019-0118-8. Published: 31 January 2019.
Source | Full text | Similar articles
Article review referring to:
Keskin DB et al., Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature. 2019 Jan;565(7738):234-239. doi: 10.1038/s41586-018-0792-9. Epub 2018 Dec 19.
Source | Full text
Hilf N et al., Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Erratum in:
Nature. 2019 Feb;566(7745):E13. Source | Full text



.

Gupta R, Sharma D.
Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy.
ACS Chem Neurosci. 2019 Mar 20;10(3):1157-1172. doi: 10.1021/acschemneuro.8b00652. Epub 2019 Feb 4.
Source | Full text | Similar articles



.

Killock D.
Lomustine-temozolomide combination efficacious in newly diagnosed glioblastoma.
Nat Rev Clin Oncol. 2019 Feb 26. doi: 10.1038/s41571-019-0192-6. [Epub ahead of print]
Source | Full text | Similar articles
Article review referring to:
Herrlinger U, et al., Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4.
Source | Full text



.

Levin VA.
How far will the Voyager® take us?
CNS Oncol. 2019 Mar;8(1):CNS26. doi: 10.2217/cns-2018-0019. Epub 2019 Feb 15.
Source | Full text | Similar articles
Editorial referring to:
Cobbs C et al., An early feasibility study of the Nativis Voyager device in patients with recurrent glioblastoma: first cohort in US.
CNS Oncol. 2019 Mar;8(1):CNS30. doi: 10.2217/cns-2018-0013. Epub 2018 Dec 14.
Source | Full text
Murphy M et al.,A feasibility study of the Nativis Voyager device in patients with recurrent glioblastoma in Australia.
CNS Oncol. 2019 Mar;8(1):CNS31. doi: 10.2217/cns-2018-0017. Epub 2019 Feb 7.
Source | Full text



.

Loo HK, Mathen P, Lee J, Camphausen K.
Circulating biomarkers for high-grade glioma.
Biomark Med. 2019 Feb;13(3):161-165. doi: 10.2217/bmm-2018-0463. Epub 2019 Feb 26.
Source | Full text | Similar articles



.

McGranahan T, Therkelsen KE, Ahmad S, Nagpal S.
Current State of Immunotherapy for Treatment of Glioblastoma.
Curr Treat Options Oncol. 2019 Feb 21;20(3):24. doi: 10.1007/s11864-019-0619-4.
Source | Full text | Similar articles



.

[No authors listed]
Progress in the fight against brain cancer.
Nature. 2019 Jan 9;565(7738):134. doi: 10.1038/d41586-019-00077-1.
Source | Full text | Similar articles
Editorial referring to:
Keskin DB et al., Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature. 2019 Jan;565(7738):234-239. doi: 10.1038/s41586-018-0792-9. Epub 2018 Dec 19.
Source | Full text
Hilf N et al., Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Erratum in:
Nature. 2019 Feb;566(7745):E13. Source | Full text
Zaidi N et al., Immune cells track hard-to-target brain tumours.
Nature. 2019 Jan;565(7738):170-171. doi: 10.1038/d41586-018-07728-9. Epub 2018 Dec 19. Source | Full text
[Article review in turn referring to:
Keskin DB et al., Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature. 2019 Jan;565(7738):234-239. doi: 10.1038/s41586-018-0792-9. Epub 2018 Dec 19.
Source | Full text
Hilf N et al., Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Erratum in:
Nature. 2019 Feb;566(7745):E13. Source | Full text ]



.

Piper K, Foster H, Gabel B, Nabors B, Cobbs C.
Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review.
Front Oncol. 2019 Jan 22;9:8. doi: 10.3389/fonc.2019.00008. eCollection 2019.
Source | Full text | Similar articles



.

Pirmoradi L, Seyfizadeh N, Ghavami S, Zeki AA, Shojaei S.
Targeting cholesterol metabolism in glioblastoma: a new therapeutic approach in cancer therapy.
J Investig Med. 2019 Apr;67(4):715-719. doi: 10.1136/jim-2018-000962. Epub 2019 Feb 14.
Source | Full text | Similar articles



.

Shepherd STC, Litchfield K, Turajlic S.
Searching for the needle in the haystack: deconvoluting the evolutionary dynamics of residual disease in human glioblastoma.
Ann Oncol. 2019 Feb 7. doi: 10.1093/annonc/mdz042. [Epub ahead of print]
Source | Full text | Similar articles
Editorial referring to: Spiteri I et al., Evolutionary dynamics of residual disease in human glioblastoma.
Ann Oncol. 2018 Nov 19. doi: 10.1093/annonc/mdy506. [Epub ahead of print].
Source | Full text



EPENDYMAL TUMORS



EPENDYMOMA



Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2019 Jan 29.
Source | Book | Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA


.

Fults DW, Taylor MD, Garzia L.
Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.
J Neurosurg Pediatr. 2019 Feb 15:1-9. doi: 10.3171/2018.11.PEDS18506. [Epub ahead of print]
Source | Abstract | Similar articles



.

Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM.
Medulloblastoma.
Nat Rev Dis Primers. 2019 Feb 14;5(1):11. doi: 10.1038/s41572-019-0063-6.
Source | Book | Similar articles | PrimeView



ATYPICAL THERATOID/RHABDOID TUMOR


.

Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2019 Jan 28.
Source | Book | Similar articles



LYMPHOMAS

.

Siegal T, Bairey O.
Primary CNS Lymphoma in the Elderly: The Challenge.
Acta Haematol. 2019 Feb 15;141(3):138-145. doi: 10.1159/000495284. [Epub ahead of print]
Source | Full text | Similar articles



bottom